In the last 12 months, insiders at Rapport Therapeutics, Inc. ($RAPP) filed 125 transactions with the SEC: 24 open-market purchases totaling $12,347,406 and 52 sales totaling $6,728,798. Net insider sentiment: net buying.
Rapport Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- HEALY JAMES (Not found) — 8 transactions totaling $9,500,008
- Ceesay Abraham (Chief Executive Officer) — 27 transactions totaling $3,496,926
- Bredt David (Chief Scientific Officer) — 27 transactions totaling $2,171,717
- HEALY JAMES (Director) — 12 transactions totaling $1,079,575
- PAUL STEVEN M (Not found) — 3 transactions totaling $1,027,111
View all SEC Filings for Rapport Therapeutics, Inc. (RAPP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Gault Cheryl | Chief Operating Officer | S | Common Stock | 2839 | $28.55 | 159,914.0000 | 47,661,138 | 1.74% | 0.01% |
| March 30, 2026 | Gault Cheryl | Chief Operating Officer | S | Common Stock | 7161 | $28.04 | 162,753.0000 | 47,661,138 | 4.21% | 0.02% |
| March 25, 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S | Common Stock | 10115 | $29.99 | 286,876.0000 | 47,661,138 | 3.41% | 0.02% |
| March 5, 2026 | Gault Cheryl | Chief Operating Officer | S | Common Stock | 2014 | $28.93 | 169,914.0000 | 47,661,138 | 1.17% | 0.00% |
| Feb. 17, 2026 | Bredt David | Chief Scientific Officer | S | Common Stock | 5400 | $28.95 | 389,275.0000 | 47,661,138 | 1.37% | 0.01% |
| Feb. 17, 2026 | Bredt David | Chief Scientific Officer | S | Common Stock | 900 | $28.02 | 394,675.0000 | 47,661,138 | 0.23% | 0.00% |
| Feb. 18, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2100 | $29.80 | 658,705.0000 | 47,661,138 | 0.32% | 0.00% |
| Feb. 18, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2281 | $29.80 | 658,705.0000 | 47,661,138 | 0.35% | 0.00% |
| Feb. 18, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 3552 | $29.05 | 660,986.0000 | 47,661,138 | 0.53% | 0.01% |
| Feb. 18, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2983 | $29.04 | 660,805.0000 | 47,661,138 | 0.45% | 0.01% |
| Feb. 19, 2026 | Bredt David | Chief Scientific Officer | M | Stock Options (Right to Buy) | 6000 | $0.00 | 88,080.0000 | 47,661,138 | 6.38% | 0.01% |
| Feb. 19, 2026 | Bredt David | Chief Scientific Officer | M | Common Stock | 6000 | $1.80 | 393,075.0000 | 47,661,138 | 1.55% | 0.01% |
| Feb. 17, 2026 | Bredt David | Chief Scientific Officer | S | Common Stock | 2200 | $29.59 | 387,075.0000 | 47,661,138 | 0.57% | 0.00% |
| Feb. 2, 2026 | Gault Cheryl | Chief Operating Officer | A | Stock Option (Right to Buy) | 132000 | $0.00 | 132,000.0000 | 47,661,138 | 9999.99% | 0.28% |
| Feb. 2, 2026 | Bredt David | Chief Scientific Officer | A | Stock Option (Right to Buy) | 103000 | $0.00 | 103,000.0000 | 47,661,138 | 9999.99% | 0.22% |
| Feb. 2, 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 47,661,138 | 9999.99% | 0.25% |
| Feb. 2, 2026 | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 148000 | $0.00 | 148,000.0000 | 47,661,138 | 9999.99% | 0.31% |
| Feb. 2, 2026 | Ceesay Abraham | Chief Executive Officer | A | Stock Option (Right to Buy) | 428000 | $0.00 | 428,000.0000 | 47,661,138 | 9999.99% | 0.90% |
| Feb. 2, 2026 | Sevigny Jeffrey | Chief Medical Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 47,661,138 | 9999.99% | 0.27% |
| Jan. 20, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 5083 | $26.11 | 669,621.0000 | 47,661,138 | 0.75% | 0.01% |
| Jan. 20, 2026 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 5833 | $26.12 | 669,621.0000 | 47,661,138 | 0.86% | 0.01% |
| Jan. 15, 2026 | Bredt David | Chief Scientific Officer | S | Common Stock | 200 | $27.40 | 395,575.0000 | 47,661,138 | 0.05% | 0.00% |
| Jan. 15, 2026 | Bredt David | Chief Scientific Officer | S | Common Stock | 8300 | $26.83 | 395,775.0000 | 47,661,138 | 2.05% | 0.02% |
| Dec. 31, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 6567 | $30.05 | 404,075.0000 | 47,661,138 | 1.60% | 0.01% |
| Dec. 31, 2025 | Yeleswaram Krishnaswamy | Chief Development Officer | S | Common Stock | 2840 | $30.05 | 296,991.0000 | 47,661,138 | 0.95% | 0.01% |
| Dec. 31, 2025 | Yeleswaram Krishnaswamy | Chief Development Officer | A | Common Stock | 9000 | $0.00 | 299,831.0000 | 47,661,138 | 3.09% | 0.02% |
| Dec. 31, 2025 | Bredt David | Chief Scientific Officer | A | Common Stock | 18000 | $0.00 | 410,642.0000 | 47,661,138 | 4.20% | 0.04% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2421 | $30.04 | 681,052.0000 | 47,661,138 | 0.35% | 0.01% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 515 | $31.04 | 680,537.0000 | 47,661,138 | 0.08% | 0.00% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2147 | $28.84 | 683,473.0000 | 47,661,138 | 0.31% | 0.00% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 600 | $31.04 | 680,537.0000 | 47,661,138 | 0.09% | 0.00% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2792 | $30.04 | 681,137.0000 | 47,661,138 | 0.41% | 0.01% |
| Dec. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2441 | $28.84 | 683,929.0000 | 47,661,138 | 0.36% | 0.01% |
| Dec. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 796 | $30.68 | 392,642.0000 | 47,661,138 | 0.20% | 0.00% |
| Dec. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 7704 | $29.95 | 393,438.0000 | 47,661,138 | 1.92% | 0.02% |
| Nov. 26, 2025 | Gault Cheryl | Chief Operating Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 105,407.0000 | 47,661,138 | 4.53% | 0.01% |
| Nov. 26, 2025 | Gault Cheryl | Chief Operating Officer | S | Common Stock | 5000 | $30.10 | 171,928.0000 | 47,661,138 | 2.83% | 0.01% |
| Nov. 26, 2025 | Gault Cheryl | Chief Operating Officer | M | Common Stock | 5000 | $1.80 | 176,928.0000 | 47,661,138 | 2.91% | 0.01% |
| Nov. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2777 | $24.92 | 694,509.0000 | 47,661,138 | 0.40% | 0.01% |
| Nov. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 3056 | $25.43 | 691,453.0000 | 47,661,138 | 0.44% | 0.01% |
| Nov. 17, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 5344 | $25.39 | 401,142.0000 | 47,661,138 | 1.31% | 0.01% |
| Nov. 17, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 3156 | $24.84 | 406,486.0000 | 47,661,138 | 0.77% | 0.01% |
| Nov. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2841 | $25.44 | 691,453.0000 | 47,661,138 | 0.41% | 0.01% |
| Nov. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 2242 | $24.91 | 694,294.0000 | 47,661,138 | 0.32% | 0.00% |
| Oct. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 1082 | $26.16 | 409,642.0000 | 36,496,437 | 0.26% | 0.00% |
| Oct. 15, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 755 | $26.17 | 702,369.0000 | 36,496,437 | 0.11% | 0.00% |
| Oct. 15, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 4328 | $25.75 | 703,124.0000 | 36,496,437 | 0.61% | 0.01% |
| Oct. 15, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 1186 | $26.14 | 702,369.0000 | 36,496,437 | 0.17% | 0.00% |
| Oct. 15, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 4647 | $25.72 | 703,555.0000 | 36,496,437 | 0.66% | 0.01% |
| Oct. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 7418 | $25.73 | 410,724.0000 | 36,496,437 | 1.77% | 0.02% |
| Sept. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 34885 | $26.30 | 713,985.0000 | 36,496,437 | 4.66% | 0.10% |
| Sept. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 39435 | $26.30 | 714,685.0000 | 36,496,437 | 5.23% | 0.11% |
| Sept. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 700 | $27.04 | 713,285.0000 | 36,496,437 | 0.10% | 0.00% |
| Sept. 17, 2025 | Ceesay Abraham | Chief Executive Officer | S | Common Stock | 1400 | $26.87 | 713,285.0000 | 36,496,437 | 0.20% | 0.00% |
| Sept. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 3402 | $24.66 | 418,142.0000 | 36,496,437 | 0.81% | 0.01% |
| Sept. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 5098 | $23.88 | 421,544.0000 | 36,496,437 | 1.19% | 0.01% |
| Sept. 12, 2025 | PAUL STEVEN M | Not found | P | Common Stock | 13382 | $24.97 | 41,666.0000 | 36,496,437 | 47.31% | 0.04% |
| Sept. 12, 2025 | PAUL STEVEN M | Not found | P | Common Stock | 28284 | $24.50 | 28,284.0000 | 36,496,437 | 9999.99% | 0.08% |
| Sept. 12, 2025 | Huber Reid M | Not found | P | Common Stock | 20400 | $24.48 | 20,400.0000 | 36,496,437 | 9999.99% | 0.06% |
| Sept. 11, 2025 | Young Wendy B. | Not found | P | Common Stock | 3500 | $22.60 | 9,500.0000 | 36,496,437 | 58.33% | 0.01% |
| Sept. 8, 2025 | Gault Cheryl | Chief Operating Officer | M | Common Stock | 5000 | $1.80 | 176,928.0000 | 36,496,437 | 2.91% | 0.01% |
| Sept. 8, 2025 | Gault Cheryl | Chief Operating Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 110,407.0000 | 36,496,437 | 4.33% | 0.01% |
| Sept. 8, 2025 | Gault Cheryl | Chief Operating Officer | S | Common Stock | 5000 | $38.33 | 171,928.0000 | 36,496,437 | 2.83% | 0.01% |
| Aug. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8300 | $14.98 | 426,842.0000 | 36,496,437 | 1.91% | 0.02% |
| Aug. 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 200 | $15.79 | 426,642.0000 | 36,496,437 | 0.05% | 0.00% |
| July 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8500 | $14.00 | 435,142.0000 | 36,496,437 | 1.92% | 0.02% |
| June 17, 2025 | Huber Reid M | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 17, 2025 | PAUL STEVEN M | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 17, 2025 | Silva Paul M | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| June 16, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8500 | $11.00 | 443,642.0000 | 36,496,437 | 1.88% | 0.02% |
| June 17, 2025 | Young Wendy B. | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| June 17, 2025 | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 17, 2025 | HEALY JAMES | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 17, 2025 | PEREZ ROBERT J | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| June 17, 2025 | Sanchez Ramiro | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| May 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8500 | $9.56 | 452,142.0000 | 36,496,437 | 1.85% | 0.02% |
| April 15, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8500 | $9.57 | 460,642.0000 | 36,496,437 | 1.81% | 0.02% |
| April 1, 2025 | Sevigny Jeffrey | Chief Medical Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 36,496,437 | 9999.99% | 0.82% |
| March 14, 2025 | Bredt David | Chief Scientific Officer | S | Common Stock | 8500 | $10.85 | 469,142.0000 | 36,496,437 | 1.78% | 0.02% |
| March 12, 2025 | Ignelzi Troy A. | Chief Financial Officer | P | Common Stock | 9900 | $10.10 | 9,900.0000 | 36,496,437 | 9999.99% | 0.03% |
| March 13, 2025 | Ignelzi Troy A. | Chief Financial Officer | P | Common Stock | 100 | $9.98 | 10,000.0000 | 36,496,437 | 1.01% | 0.00% |
| March 12, 2025 | Young Wendy B. | Not found | P | Common Stock | 6000 | $10.21 | 6,000.0000 | 36,496,437 | 9999.99% | 0.02% |
| March 3, 2025 | Gault Cheryl | Chief Operating Officer | A | Common Stock | 13987 | $0.00 | 171,928.0000 | 36,496,437 | 8.86% | 0.04% |
| Feb. 3, 2025 | Yeleswaram Krishnaswamy | Chief Development Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 142000 | $0.00 | 142,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Bredt David | Chief Scientific Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Ceesay Abraham | Chief Executive Officer | A | Stock Option (Right to Buy) | 428000 | $0.00 | 428,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Gault Cheryl | Chief Operating Officer | A | Stock Option (Right to Buy) | 129000 | $0.00 | 129,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2024 | Young Wendy B. | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2024 | PEREZ ROBERT J | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2024 | Silva Paul M | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2024 | Sanchez Ramiro | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3799 | $23.08 | 1,984,140.0000 | 0 | 0.19% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 2625 | $26.06 | 1,995,594.0000 | 0 | 0.13% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 4661 | $25.02 | 1,992,969.0000 | 0 | 0.23% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3657 | $24.21 | 1,988,308.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3630 | $23.08 | 1,984,651.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 2748 | $26.06 | 1,995,594.0000 | 0 | 0.14% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 4878 | $25.02 | 1,992,846.0000 | 0 | 0.25% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3828 | $24.21 | 1,987,968.0000 | 0 | 0.19% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 2559 | $26.06 | 1,995,594.0000 | 0 | 0.13% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 4544 | $25.02 | 1,993,035.0000 | 0 | 0.23% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3565 | $24.21 | 1,988,491.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | HEALY JAMES | Director | P | Common Stock | 3538 | $23.08 | 1,984,926.0000 | 0 | 0.18% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | C | Series B Preferred Stock | 11924138 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | ARCH Venture Partners XII, LLC | Not found | C | Common Stock | 3728738 | $0.00 | 3,728,738.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | ARCH Venture Partners XII, LLC | Not found | C | Series A Preferred Stock | 20000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | ARCH Venture Partners XII, LLC | Not found | C | Series B Preferred Stock | 11924138 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 6, 2024 | Galer Bradley S. | Chief Medical Officer | A | Stock Option (Right to Buy) | 123818 | $0.00 | 123,818.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Gault Cheryl | Chief Operations Officer | A | Stock Option (Right to Buy) | 88442 | $0.00 | 88,442.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Bredt David | Chief Scientific Officer | A | Stock Option (Right to Buy) | 28302 | $0.00 | 28,302.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Yeleswaram Krishnaswamy | Chief Development Officer | A | Stock Option (Right to Buy) | 84904 | $0.00 | 84,904.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 6551449 | $0.00 | 8,104,451.0000 | 0 | 421.86% | 0.00% |
| June 10, 2024 | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 969218 | $0.00 | 8,104,451.0000 | 0 | 13.58% | 0.00% |
| June 10, 2024 | Third Rock Ventures V, L.P. | Not found | C | Series A Preferred Stock | 56091177 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Third Rock Ventures V, L.P. | Not found | C | Series A Preferred Stock | 8000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Third Rock Ventures V, L.P. | Not found | C | Series B Preferred Stock | 298103 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 6, 2024 | Ceesay Abraham | Chief Executive Officer | A | Stock Option (Right to Buy) | 530647 | $0.00 | 530,647.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | C | Common Stock | 1392738 | $0.00 | 1,480,973.0000 | 0 | 1578.44% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | P | Common Stock | 470589 | $17.00 | 1,951,562.0000 | 0 | 31.78% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | P | Common Stock | 18641 | $17.00 | 1,951,562.0000 | 0 | 0.96% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | P | Common Stock | 17861 | $17.00 | 1,951,562.0000 | 0 | 0.92% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | P | Common Stock | 26278 | $17.00 | 1,951,562.0000 | 0 | 1.36% | 0.00% |
| June 10, 2024 | HEALY JAMES | Not found | P | Common Stock | 25455 | $17.00 | 1,951,562.0000 | 0 | 1.32% | 0.00% |
| June 6, 2024 | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 81366 | $0.00 | 81,366.0000 | 0 | 9999.99% | 0.00% |